Spectral Genomics Introduces SpectralWare(TM) Webware for the Analysis and Reporting of Array CGH Data

Spectral Genomics, Inc.(R) announced today the introduction of its web-enabled SpectralWare(TM), a software suite for the analysis and reporting of data from array Comparative Genomic Hybridization (CGH).  The webware concept allows every user of SpectralWare to have the latest version of software as soon as it is available.  Further, research and clinical data generated by customers is stored in the user’s laboratory server and remains confidential.  Used with Spectral’s innovative SpectralChip(TM) 2600 and Constitutional Chip(TM) 1.0 for array CGH, SpectralWare automatically processes data produced by standard microarray laser scanners and displays the ratios of signals produced in Spectral’s two dye detection system.  Adjustable for the parameters of each array, SpectralWare treats array data to take advantage of the most favorable statistical strategies for evaluating CGH results, optimizing the array signals.  SpectraWare displays the CGH ratios characteristic of genetic amplifications and deletions along a graphical representation of the chromosome ideogram with classical cytogenetic banding represented along the length of each chromosome.  Amplifications and deletions are color coded and clearly illustrated with the cytogenetic position of structural changes in the genome characteristic of genetic defects or cancer.  Using interactive cursors, researchers can explore the deletions and amplifications detected by Spectral CGH arrays and obtain exact identity of the BAC clones on the array that appear in the regions of interest as well as the specific genes involved from various bioinformatic data bases.  SpectralWare also produces a final cytogenetics report that can be used directly in reporting clinical diagnostic data for research, genetic counseling and oncology.

Ed Chait, Spectral Genomics’ CEO said, “It is particularly exciting that the information technology group at Spectral who pioneered web-based software for molecular diagnostics in our DiversiLab(TM) system is introducing this major innovation in cytogenetic data presentation allowing our customers and collaborators to fully experience the superior data that can be obtained from our BAC clone microarrays.”

Spectral Genomics, a pioneer in technology for the genome with headquarters in Houston, TX, is a global supplier of innovative products for human and microbial genetics and provides services for customers in academic and industrial research laboratories, including the DiversiLab(TM) system for microbial strain typing.

http://www.spectralgenomics.com